Biodegradable Stents in Primary Sclerosing Cholangitis
NCT: NCT07607353 · RECRUITING
Brief Summary
In patients with PSC, endoscopic therapy of strictures aims to improve cholestasis by relieving the biliary obstruction via endoscopic biliary dilatation with consideration of plastic stents in strictures refractory to dilatation due to the risk of pancreatitis and cholangitis . Short term stents have been shown to have similar recurrence-free rates compared to dilatation in a randomised control trial; however, this was terminated after interim analysis due to higher rates of serious adverse events in the stent group. The long term benefits are unclear; however, it may lead to improved survival compared to predicted survival. In this group of patients with limited treatment options, biodegradable stents may provide an attractive additional treatment modality in the management of high grade strictures.
Frequently Asked Questions
What is Biodegradable Stents in Primary Sclerosing Cholangitis?
Biodegradable Stents in Primary Sclerosing Cholangitis is a clinical trial registered under NCT07607353. Current status: RECRUITING.
What is the status of NCT07607353?
The current status of NCT07607353 (Biodegradable Stents in Primary Sclerosing Cholangitis) is: RECRUITING.
When did Biodegradable Stents in Primary Sclerosing Cholangitis start?
Biodegradable Stents in Primary Sclerosing Cholangitis started on 2026-03-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.